4-(4-Methyl-pyridin-2-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H25N3O2, MW: 291.39
|
- $501.08 - $635
- Product name: 4-(4-Methyl-pyridin-2-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H25N3O2, MW: 291.39
- CAS: 939986-29-5
- MF: C16H25N3O2
- MW: 291.39
- EINECS:
- MDL Number:MFCD09607556
- Synonyms:4-(4-Methyl-pyridin-2-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H25N3O2, MW: 291.39;4-[(4-Methyl-2-pyridinyl)amino]-1-piperidinecarboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 4-[(4-methyl-2-pyridinyl)amino]-, 1,1-dimethylethyl ester
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0238209
- Product descriptionTERT-BUTYL-4-((4-METHYLPYRIDIN-2-YL)AMINO)PIPERIDINE-1-CARBOXYLATE 95.00%
- Packaging5MG
- Price$501.08
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM173531
- Product descriptiontert-butyl4-((4-methylpyridin-2-yl)amino)piperidine-1-carboxylate 95%
- Packaging1g
- Price$599
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11008288
- Product descriptiontert-Butyl4-((4-methylpyridin-2-yl)amino)piperidine-1-carboxylate 95+%
- Packaging1g
- Price$635
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0238209 | TERT-BUTYL-4-((4-METHYLPYRIDIN-2-YL)AMINO)PIPERIDINE-1-CARBOXYLATE 95.00% | 5MG | $501.08 | 2021-12-16 | Buy |
| Chemenu | CM173531 | tert-butyl4-((4-methylpyridin-2-yl)amino)piperidine-1-carboxylate 95% | 1g | $599 | 2021-12-16 | Buy |
| Crysdot | CD11008288 | tert-Butyl4-((4-methylpyridin-2-yl)amino)piperidine-1-carboxylate 95+% | 1g | $635 | 2021-12-16 | Buy |
Properties
Density :1.124
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|